Lexpos News

Community pharmacy owners are being asked to share their experiences of patient abuse towards them and their teams, and other challenges, as the Community Pharmacy England Committee prepares for its first meeting of 2026. Pharmacy owners and their teams continue to work hard to support local communities despite mounting pressures, and this is made even [...]

The post Sector Poll: Tell us about patient abuse and other challenges appeared first on Community Pharmacy England.

Community Pharmacy England’s political influencing work with our public affairs partner, Luther Pendragon, has been recognised in the Public Affairs Awards 2026. Together, Luther Pendragon and Community Pharmacy England have been selected as finalists in the category of Best In-House Consultancy Collaboration for our joint campaign to press for increased funding for community pharmacies. The recognition reflects the impact of our work together to help secure further investment for [...]

The post CPE and Luther Pendragon Named Finalists at Public Affairs Awards 2026 appeared first on Community Pharmacy England.

The Independent, The Guardian, Daily Mail,  The Sun, Yahoo News, LBC News Reports in the media have suggested that pharmacies across England are running low on flu vaccines, with potential shortages of appointments in some isolated areas. Reports indicate that a particularly infectious strain is driving what could be the worst flu season on record [...]

The post Pharmacies manage surging flu vaccine demand appeared first on Community Pharmacy England.

Following public calls to encourage people to get their flu vaccination to be protected ahead of the festive holidays, NHS England has assured pharmacy owners that flu vaccine stocks remain available to order. Where pharmacy owners have exhausted their original flu vaccine stock, flu vaccine supply may still be available from some wholesalers. Alternatively, as [...]

The post Flu Vac: Vaccine stock availability appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Clarithromycin 500 mg powder for concentrate for solution for infusion (Hameln Pharma Ltd) Drug alert number: EL(25)A/53 Date issued: 11 December 2025 Hameln Pharma Ltd is recalling certain batches of Clarithromycin 500 mg powder for concentrate for solution for infusion. DMRC reference number: DMRC-37790612 Company name: Hameln Pharma ltd Medicine Details [...]

The post MHRA Class 2 Medicines Recall: Clarithromycin 500 mg powder for concentrate for solution for infusion (Hameln Pharma Ltd) appeared first on Community Pharmacy England.